3rd International Conference on Central Nervous System Disorders & Therapeutics

3rd International Conference on Central Nervous System Disorders & Therapeutics
Oct 02-04, 2017 Vienna, Austria
Theme: Accelerate the Diagnosis, Prevention & Management of CNS Disorders
CNS 2017 Webpage: http://cns.conferenceseries.com/

It’s our pleasure to invite all the participants from all over the world to attend the 3rd International Conference on Central Nervous System Disorders and Therapeutics which is held during Oct 02-04, 2017 at Vienna, Austria.

The main theme of our conference is “Accelerate the Diagnosis, Prevention & Management of CNS Disorders” which covers a wide range of critically important sessions.

“The live format of the conference will be accredited with CME and CPD Credits”

CNS disorders can affect either the brain or the spinal cord, resulting in neurological or psychiatric disorders. Causes of central nervous system diseases are trauma, infections, degeneration, autoimmune disorders, structural defects, tumors, and stroke.

CNS 2017 to bring together worldwide distinguished academics in the field of Neuro-oncologist, Neuropharmacology, Neurology, Neuropediatrics, Pediatric Oncologists, Neurosurgeons, Neurophysiologists, Neuroscience Brain researchers, Public Health professionals, Scientists, Academic scientists, Industry researchers, Scholars to exchange about state of the art Research and Technologies and to bring discoveries of CNS disorders to Patients. Attending International conference is for the Professional Development and to understand the current state of research and the challenges to future discovery.

A central nervous system disease can affect either the spinal cord (myelopathy) or brain (encephalopathy), both of which are part of the central nervous system. The nervous system is vulnerable to various disorders. It can be damaged by the following Trauma, infections, blood flow disruption, tumors, autoimmune disorders etc. Disorders of the central nervous system may involve the following:
• Vascular Disorders: Stroke, Transient ischemic attack (TIA), Subarachnoid hemorrhage, Subdural hemorrhage and Hematoma, and Extradural hemorrhage
• Infections: Meningitis, Encephalitis, and epidural abscess
• Structural disorders: Brain or Spinal cord injury, Bell’s palsy, cervical spondylosis, Carpal tunnel syndrome, Brain or Spinal cord tumors
• Functional disorders: A headache, Epilepsy, Dizziness, and Neuralgia
• Degenerative disorders: Parkinson disease, Multiple sclerosis, Amyotrophic lateral sclerosis (ALS), Huntington chorea, and Alzheimer disease.

In addition, the geographical distribution of CNS disorder and market across the US, the top five countries of Europe and in Japan. The report also includes insights into the CNS disorder R&D product pipeline and explores the competitive landscape including major players in CNS disease market. Finally, the report also includes analysis of Mergers and Acquisitions (M&As) and licensing agreements that took place in CNS disorder therapeutics market.
In order to accelerate the research in the field of Neuroscience, ConferenceSeries Ltd organizes different conference series worldwide.

Conference Highlights
Central Nervous System Disorders
Neuropsychiatry
Cerebral Disorders
Neuronal Disorders
CNS and Neuro Surgery
Neurochemical Transmission
Neuro Oncology and CNS
Cognitive Neurology
Spinal Cord
Signal Transduction and CNS
Genesis of Neurons
Neuro Pharmaceutics
Clinical aspects of CNS
Case Study on CNS
Clinical Trials on CNS
CNS Biomarkers
Perspective in Neuroscience and Neurology
Novel Neurotherapeutics

Let’s meet in the city of music, Vienna.

Contact Details:

Alberto Kent
Program Manager | CNS 2017
P: +1-702-508-5200 Ext 8034
E: cns@neuroconferences.com
UK: Kemp House, 152 City Road, London EC1V 2NX
USA: One Commerce Center-1201 Orange St. #600 Wilmington, Zip 19899, Delaware, USA